nodes	percent_of_prediction	percent_of_DWPC	metapath
Atomoxetine—HTR1B—dura mater—ankylosing spondylitis	0.08	0.469	CbGeAlD
Atomoxetine—HTR1D—dura mater—ankylosing spondylitis	0.0774	0.454	CbGeAlD
Atomoxetine—CYP2C19—Prednisone—ankylosing spondylitis	0.0771	0.188	CbGbCtD
Atomoxetine—CYP3A4—Methylprednisolone—ankylosing spondylitis	0.0616	0.15	CbGbCtD
Atomoxetine—CYP2C19—Dexamethasone—ankylosing spondylitis	0.0482	0.117	CbGbCtD
Atomoxetine—CYP3A4—Triamcinolone—ankylosing spondylitis	0.0467	0.114	CbGbCtD
Atomoxetine—CYP3A4—Betamethasone—ankylosing spondylitis	0.04	0.0975	CbGbCtD
Atomoxetine—CYP3A4—Prednisolone—ankylosing spondylitis	0.0395	0.0962	CbGbCtD
Atomoxetine—CYP3A4—Prednisone—ankylosing spondylitis	0.0373	0.0909	CbGbCtD
Atomoxetine—CYP2D6—Dexamethasone—ankylosing spondylitis	0.0366	0.0892	CbGbCtD
Atomoxetine—CYP3A4—Dexamethasone—ankylosing spondylitis	0.0233	0.0567	CbGbCtD
Atomoxetine—HTR2A—vertebral column—ankylosing spondylitis	0.0116	0.0677	CbGeAlD
Atomoxetine—HTR2A—tendon—ankylosing spondylitis	0.00167	0.0098	CbGeAlD
Atomoxetine—Depression—Prednisone—ankylosing spondylitis	0.00101	0.00242	CcSEcCtD
Atomoxetine—Mental disorder—Methylprednisolone—ankylosing spondylitis	0.00101	0.00241	CcSEcCtD
Atomoxetine—Malnutrition—Methylprednisolone—ankylosing spondylitis	0.001	0.0024	CcSEcCtD
Atomoxetine—Breast disorder—Methotrexate—ankylosing spondylitis	0.000997	0.00238	CcSEcCtD
Atomoxetine—Dysgeusia—Triamcinolone—ankylosing spondylitis	0.000986	0.00235	CcSEcCtD
Atomoxetine—Vertigo—Prednisolone—ankylosing spondylitis	0.000983	0.00235	CcSEcCtD
Atomoxetine—Syncope—Prednisolone—ankylosing spondylitis	0.000981	0.00234	CcSEcCtD
Atomoxetine—Back pain—Triamcinolone—ankylosing spondylitis	0.000974	0.00232	CcSEcCtD
Atomoxetine—Loss of consciousness—Prednisolone—ankylosing spondylitis	0.000962	0.0023	CcSEcCtD
Atomoxetine—Angiopathy—Betamethasone—ankylosing spondylitis	0.000952	0.00227	CcSEcCtD
Atomoxetine—Angiopathy—Dexamethasone—ankylosing spondylitis	0.000952	0.00227	CcSEcCtD
Atomoxetine—Convulsion—Prednisolone—ankylosing spondylitis	0.000948	0.00226	CcSEcCtD
Atomoxetine—Abdominal discomfort—Methotrexate—ankylosing spondylitis	0.000914	0.00218	CcSEcCtD
Atomoxetine—Hallucination—Prednisone—ankylosing spondylitis	0.000909	0.00217	CcSEcCtD
Atomoxetine—Vertigo—Triamcinolone—ankylosing spondylitis	0.000904	0.00216	CcSEcCtD
Atomoxetine—Syncope—Triamcinolone—ankylosing spondylitis	0.000903	0.00215	CcSEcCtD
Atomoxetine—Vertigo—Methylprednisolone—ankylosing spondylitis	0.000902	0.00215	CcSEcCtD
Atomoxetine—Syncope—Methylprednisolone—ankylosing spondylitis	0.000901	0.00215	CcSEcCtD
Atomoxetine—Dysuria—Methotrexate—ankylosing spondylitis	0.000892	0.00213	CcSEcCtD
Atomoxetine—Upper respiratory tract infection—Methotrexate—ankylosing spondylitis	0.000887	0.00212	CcSEcCtD
Atomoxetine—Loss of consciousness—Triamcinolone—ankylosing spondylitis	0.000885	0.00211	CcSEcCtD
Atomoxetine—Loss of consciousness—Methylprednisolone—ankylosing spondylitis	0.000883	0.00211	CcSEcCtD
Atomoxetine—Shock—Prednisolone—ankylosing spondylitis	0.000879	0.0021	CcSEcCtD
Atomoxetine—Erectile dysfunction—Methotrexate—ankylosing spondylitis	0.000879	0.0021	CcSEcCtD
Atomoxetine—Cough—Triamcinolone—ankylosing spondylitis	0.000878	0.0021	CcSEcCtD
Atomoxetine—Convulsion—Triamcinolone—ankylosing spondylitis	0.000872	0.00208	CcSEcCtD
Atomoxetine—Tachycardia—Prednisolone—ankylosing spondylitis	0.000872	0.00208	CcSEcCtD
Atomoxetine—Convulsion—Methylprednisolone—ankylosing spondylitis	0.00087	0.00208	CcSEcCtD
Atomoxetine—Hyperhidrosis—Prednisolone—ankylosing spondylitis	0.000863	0.00206	CcSEcCtD
Atomoxetine—Myalgia—Triamcinolone—ankylosing spondylitis	0.000857	0.00204	CcSEcCtD
Atomoxetine—Arthralgia—Methylprednisolone—ankylosing spondylitis	0.000855	0.00204	CcSEcCtD
Atomoxetine—Myalgia—Methylprednisolone—ankylosing spondylitis	0.000855	0.00204	CcSEcCtD
Atomoxetine—Anxiety—Methylprednisolone—ankylosing spondylitis	0.000852	0.00203	CcSEcCtD
Atomoxetine—Infestation NOS—Methotrexate—ankylosing spondylitis	0.000851	0.00203	CcSEcCtD
Atomoxetine—Infestation—Methotrexate—ankylosing spondylitis	0.000851	0.00203	CcSEcCtD
Atomoxetine—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ankylosing spondylitis	0.000849	0.00203	CcSEcCtD
Atomoxetine—Depression—Methotrexate—ankylosing spondylitis	0.000848	0.00202	CcSEcCtD
Atomoxetine—Flushing—Prednisone—ankylosing spondylitis	0.000848	0.00202	CcSEcCtD
Atomoxetine—Dry mouth—Triamcinolone—ankylosing spondylitis	0.000838	0.002	CcSEcCtD
Atomoxetine—Angiopathy—Prednisone—ankylosing spondylitis	0.000829	0.00198	CcSEcCtD
Atomoxetine—Conjunctivitis—Methotrexate—ankylosing spondylitis	0.000827	0.00197	CcSEcCtD
Atomoxetine—Vertigo—Dexamethasone—ankylosing spondylitis	0.00082	0.00196	CcSEcCtD
Atomoxetine—Vertigo—Betamethasone—ankylosing spondylitis	0.00082	0.00196	CcSEcCtD
Atomoxetine—Syncope—Dexamethasone—ankylosing spondylitis	0.000819	0.00195	CcSEcCtD
Atomoxetine—Syncope—Betamethasone—ankylosing spondylitis	0.000819	0.00195	CcSEcCtD
Atomoxetine—Infection—Triamcinolone—ankylosing spondylitis	0.000816	0.00195	CcSEcCtD
Atomoxetine—Infection—Methylprednisolone—ankylosing spondylitis	0.000814	0.00194	CcSEcCtD
Atomoxetine—Shock—Triamcinolone—ankylosing spondylitis	0.000808	0.00193	CcSEcCtD
Atomoxetine—Insomnia—Prednisolone—ankylosing spondylitis	0.000808	0.00193	CcSEcCtD
Atomoxetine—Shock—Methylprednisolone—ankylosing spondylitis	0.000806	0.00192	CcSEcCtD
Atomoxetine—Nervous system disorder—Methylprednisolone—ankylosing spondylitis	0.000804	0.00192	CcSEcCtD
Atomoxetine—Loss of consciousness—Betamethasone—ankylosing spondylitis	0.000803	0.00192	CcSEcCtD
Atomoxetine—Loss of consciousness—Dexamethasone—ankylosing spondylitis	0.000803	0.00192	CcSEcCtD
Atomoxetine—Paraesthesia—Prednisolone—ankylosing spondylitis	0.000802	0.00191	CcSEcCtD
Atomoxetine—Tachycardia—Triamcinolone—ankylosing spondylitis	0.000802	0.00191	CcSEcCtD
Atomoxetine—Mental disorder—Prednisone—ankylosing spondylitis	0.0008	0.00191	CcSEcCtD
Atomoxetine—Tachycardia—Methylprednisolone—ankylosing spondylitis	0.0008	0.00191	CcSEcCtD
Atomoxetine—Skin disorder—Methylprednisolone—ankylosing spondylitis	0.000796	0.0019	CcSEcCtD
Atomoxetine—Malnutrition—Prednisone—ankylosing spondylitis	0.000795	0.0019	CcSEcCtD
Atomoxetine—Hyperhidrosis—Triamcinolone—ankylosing spondylitis	0.000794	0.00189	CcSEcCtD
Atomoxetine—Hyperhidrosis—Methylprednisolone—ankylosing spondylitis	0.000792	0.00189	CcSEcCtD
Atomoxetine—Convulsion—Dexamethasone—ankylosing spondylitis	0.000791	0.00189	CcSEcCtD
Atomoxetine—Convulsion—Betamethasone—ankylosing spondylitis	0.000791	0.00189	CcSEcCtD
Atomoxetine—Myalgia—Betamethasone—ankylosing spondylitis	0.000777	0.00186	CcSEcCtD
Atomoxetine—Myalgia—Dexamethasone—ankylosing spondylitis	0.000777	0.00186	CcSEcCtD
Atomoxetine—Anxiety—Dexamethasone—ankylosing spondylitis	0.000775	0.00185	CcSEcCtD
Atomoxetine—Anxiety—Betamethasone—ankylosing spondylitis	0.000775	0.00185	CcSEcCtD
Atomoxetine—Pain—Prednisolone—ankylosing spondylitis	0.000764	0.00182	CcSEcCtD
Atomoxetine—Urinary tract disorder—Methotrexate—ankylosing spondylitis	0.000754	0.0018	CcSEcCtD
Atomoxetine—Vision blurred—Prednisone—ankylosing spondylitis	0.00075	0.00179	CcSEcCtD
Atomoxetine—Urethral disorder—Methotrexate—ankylosing spondylitis	0.000748	0.00179	CcSEcCtD
Atomoxetine—Musculoskeletal discomfort—Triamcinolone—ankylosing spondylitis	0.000748	0.00179	CcSEcCtD
Atomoxetine—Musculoskeletal discomfort—Methylprednisolone—ankylosing spondylitis	0.000747	0.00178	CcSEcCtD
Atomoxetine—Insomnia—Triamcinolone—ankylosing spondylitis	0.000743	0.00177	CcSEcCtD
Atomoxetine—Insomnia—Methylprednisolone—ankylosing spondylitis	0.000741	0.00177	CcSEcCtD
Atomoxetine—Infection—Dexamethasone—ankylosing spondylitis	0.00074	0.00177	CcSEcCtD
Atomoxetine—Infection—Betamethasone—ankylosing spondylitis	0.00074	0.00177	CcSEcCtD
Atomoxetine—Paraesthesia—Triamcinolone—ankylosing spondylitis	0.000738	0.00176	CcSEcCtD
Atomoxetine—Feeling abnormal—Prednisolone—ankylosing spondylitis	0.000736	0.00176	CcSEcCtD
Atomoxetine—Paraesthesia—Methylprednisolone—ankylosing spondylitis	0.000736	0.00176	CcSEcCtD
Atomoxetine—Shock—Dexamethasone—ankylosing spondylitis	0.000733	0.00175	CcSEcCtD
Atomoxetine—Shock—Betamethasone—ankylosing spondylitis	0.000733	0.00175	CcSEcCtD
Atomoxetine—Nervous system disorder—Dexamethasone—ankylosing spondylitis	0.000731	0.00174	CcSEcCtD
Atomoxetine—Nervous system disorder—Betamethasone—ankylosing spondylitis	0.000731	0.00174	CcSEcCtD
Atomoxetine—Agitation—Prednisone—ankylosing spondylitis	0.000731	0.00174	CcSEcCtD
Atomoxetine—Tachycardia—Betamethasone—ankylosing spondylitis	0.000727	0.00174	CcSEcCtD
Atomoxetine—Tachycardia—Dexamethasone—ankylosing spondylitis	0.000727	0.00174	CcSEcCtD
Atomoxetine—Dyspepsia—Triamcinolone—ankylosing spondylitis	0.000723	0.00173	CcSEcCtD
Atomoxetine—Dyspepsia—Methylprednisolone—ankylosing spondylitis	0.000721	0.00172	CcSEcCtD
Atomoxetine—Hyperhidrosis—Dexamethasone—ankylosing spondylitis	0.000721	0.00172	CcSEcCtD
Atomoxetine—Hyperhidrosis—Betamethasone—ankylosing spondylitis	0.000721	0.00172	CcSEcCtD
Atomoxetine—Vertigo—Prednisone—ankylosing spondylitis	0.000715	0.00171	CcSEcCtD
Atomoxetine—Syncope—Prednisone—ankylosing spondylitis	0.000713	0.0017	CcSEcCtD
Atomoxetine—Anorexia—Dexamethasone—ankylosing spondylitis	0.00071	0.0017	CcSEcCtD
Atomoxetine—Anorexia—Betamethasone—ankylosing spondylitis	0.00071	0.0017	CcSEcCtD
Atomoxetine—Urticaria—Prednisolone—ankylosing spondylitis	0.00071	0.00169	CcSEcCtD
Atomoxetine—Cardiac disorder—Methotrexate—ankylosing spondylitis	0.000709	0.00169	CcSEcCtD
Atomoxetine—Fatigue—Triamcinolone—ankylosing spondylitis	0.000708	0.00169	CcSEcCtD
Atomoxetine—Fatigue—Methylprednisolone—ankylosing spondylitis	0.000707	0.00169	CcSEcCtD
Atomoxetine—Pain—Triamcinolone—ankylosing spondylitis	0.000702	0.00168	CcSEcCtD
Atomoxetine—Loss of consciousness—Prednisone—ankylosing spondylitis	0.000699	0.00167	CcSEcCtD
Atomoxetine—Angiopathy—Methotrexate—ankylosing spondylitis	0.000693	0.00165	CcSEcCtD
Atomoxetine—Convulsion—Prednisone—ankylosing spondylitis	0.000689	0.00164	CcSEcCtD
Atomoxetine—Mediastinal disorder—Methotrexate—ankylosing spondylitis	0.000688	0.00164	CcSEcCtD
Atomoxetine—Chills—Methotrexate—ankylosing spondylitis	0.000685	0.00163	CcSEcCtD
Atomoxetine—Musculoskeletal discomfort—Dexamethasone—ankylosing spondylitis	0.000679	0.00162	CcSEcCtD
Atomoxetine—Musculoskeletal discomfort—Betamethasone—ankylosing spondylitis	0.000679	0.00162	CcSEcCtD
Atomoxetine—Arthralgia—Prednisone—ankylosing spondylitis	0.000677	0.00162	CcSEcCtD
Atomoxetine—Myalgia—Prednisone—ankylosing spondylitis	0.000677	0.00162	CcSEcCtD
Atomoxetine—Feeling abnormal—Triamcinolone—ankylosing spondylitis	0.000677	0.00162	CcSEcCtD
Atomoxetine—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	0.000675	0.00161	CcSEcCtD
Atomoxetine—Anxiety—Prednisone—ankylosing spondylitis	0.000675	0.00161	CcSEcCtD
Atomoxetine—Insomnia—Betamethasone—ankylosing spondylitis	0.000674	0.00161	CcSEcCtD
Atomoxetine—Insomnia—Dexamethasone—ankylosing spondylitis	0.000674	0.00161	CcSEcCtD
Atomoxetine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ankylosing spondylitis	0.000672	0.0016	CcSEcCtD
Atomoxetine—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	0.00067	0.0016	CcSEcCtD
Atomoxetine—Paraesthesia—Dexamethasone—ankylosing spondylitis	0.000669	0.0016	CcSEcCtD
Atomoxetine—Paraesthesia—Betamethasone—ankylosing spondylitis	0.000669	0.0016	CcSEcCtD
Atomoxetine—Mental disorder—Methotrexate—ankylosing spondylitis	0.000669	0.0016	CcSEcCtD
Atomoxetine—Malnutrition—Methotrexate—ankylosing spondylitis	0.000665	0.00159	CcSEcCtD
Atomoxetine—Dyspepsia—Dexamethasone—ankylosing spondylitis	0.000656	0.00157	CcSEcCtD
Atomoxetine—Dyspepsia—Betamethasone—ankylosing spondylitis	0.000656	0.00157	CcSEcCtD
Atomoxetine—Urticaria—Triamcinolone—ankylosing spondylitis	0.000653	0.00156	CcSEcCtD
Atomoxetine—Urticaria—Methylprednisolone—ankylosing spondylitis	0.000651	0.00155	CcSEcCtD
Atomoxetine—Dysgeusia—Methotrexate—ankylosing spondylitis	0.000651	0.00155	CcSEcCtD
Atomoxetine—Body temperature increased—Triamcinolone—ankylosing spondylitis	0.000649	0.00155	CcSEcCtD
Atomoxetine—Abdominal pain—Methylprednisolone—ankylosing spondylitis	0.000648	0.00155	CcSEcCtD
Atomoxetine—Decreased appetite—Dexamethasone—ankylosing spondylitis	0.000648	0.00155	CcSEcCtD
Atomoxetine—Decreased appetite—Betamethasone—ankylosing spondylitis	0.000648	0.00155	CcSEcCtD
Atomoxetine—Infection—Prednisone—ankylosing spondylitis	0.000645	0.00154	CcSEcCtD
Atomoxetine—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	0.000643	0.00154	CcSEcCtD
Atomoxetine—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	0.000643	0.00154	CcSEcCtD
Atomoxetine—Back pain—Methotrexate—ankylosing spondylitis	0.000643	0.00153	CcSEcCtD
Atomoxetine—Fatigue—Dexamethasone—ankylosing spondylitis	0.000643	0.00153	CcSEcCtD
Atomoxetine—Fatigue—Betamethasone—ankylosing spondylitis	0.000643	0.00153	CcSEcCtD
Atomoxetine—Shock—Prednisone—ankylosing spondylitis	0.000639	0.00152	CcSEcCtD
Atomoxetine—Pain—Dexamethasone—ankylosing spondylitis	0.000637	0.00152	CcSEcCtD
Atomoxetine—Pain—Betamethasone—ankylosing spondylitis	0.000637	0.00152	CcSEcCtD
Atomoxetine—Nervous system disorder—Prednisone—ankylosing spondylitis	0.000637	0.00152	CcSEcCtD
Atomoxetine—Tachycardia—Prednisone—ankylosing spondylitis	0.000633	0.00151	CcSEcCtD
Atomoxetine—Skin disorder—Prednisone—ankylosing spondylitis	0.00063	0.0015	CcSEcCtD
Atomoxetine—Hyperhidrosis—Prednisone—ankylosing spondylitis	0.000627	0.0015	CcSEcCtD
Atomoxetine—Vision blurred—Methotrexate—ankylosing spondylitis	0.000626	0.00149	CcSEcCtD
Atomoxetine—Anorexia—Prednisone—ankylosing spondylitis	0.000619	0.00148	CcSEcCtD
Atomoxetine—Feeling abnormal—Dexamethasone—ankylosing spondylitis	0.000614	0.00147	CcSEcCtD
Atomoxetine—Feeling abnormal—Betamethasone—ankylosing spondylitis	0.000614	0.00147	CcSEcCtD
Atomoxetine—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	0.000609	0.00145	CcSEcCtD
Atomoxetine—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	0.000609	0.00145	CcSEcCtD
Atomoxetine—Vertigo—Methotrexate—ankylosing spondylitis	0.000597	0.00143	CcSEcCtD
Atomoxetine—Urticaria—Dexamethasone—ankylosing spondylitis	0.000592	0.00141	CcSEcCtD
Atomoxetine—Urticaria—Betamethasone—ankylosing spondylitis	0.000592	0.00141	CcSEcCtD
Atomoxetine—Musculoskeletal discomfort—Prednisone—ankylosing spondylitis	0.000591	0.00141	CcSEcCtD
Atomoxetine—Dizziness—Prednisolone—ankylosing spondylitis	0.000591	0.00141	CcSEcCtD
Atomoxetine—Asthenia—Triamcinolone—ankylosing spondylitis	0.000589	0.00141	CcSEcCtD
Atomoxetine—Abdominal pain—Betamethasone—ankylosing spondylitis	0.000589	0.00141	CcSEcCtD
Atomoxetine—Abdominal pain—Dexamethasone—ankylosing spondylitis	0.000589	0.00141	CcSEcCtD
Atomoxetine—Body temperature increased—Dexamethasone—ankylosing spondylitis	0.000589	0.00141	CcSEcCtD
Atomoxetine—Body temperature increased—Betamethasone—ankylosing spondylitis	0.000589	0.00141	CcSEcCtD
Atomoxetine—Asthenia—Methylprednisolone—ankylosing spondylitis	0.000588	0.0014	CcSEcCtD
Atomoxetine—Insomnia—Prednisone—ankylosing spondylitis	0.000587	0.0014	CcSEcCtD
Atomoxetine—Paraesthesia—Prednisone—ankylosing spondylitis	0.000583	0.00139	CcSEcCtD
Atomoxetine—Pruritus—Triamcinolone—ankylosing spondylitis	0.000581	0.00139	CcSEcCtD
Atomoxetine—Cough—Methotrexate—ankylosing spondylitis	0.00058	0.00138	CcSEcCtD
Atomoxetine—Pruritus—Methylprednisolone—ankylosing spondylitis	0.00058	0.00138	CcSEcCtD
Atomoxetine—Convulsion—Methotrexate—ankylosing spondylitis	0.000576	0.00137	CcSEcCtD
Atomoxetine—Dyspepsia—Prednisone—ankylosing spondylitis	0.000571	0.00136	CcSEcCtD
Atomoxetine—Arthralgia—Methotrexate—ankylosing spondylitis	0.000566	0.00135	CcSEcCtD
Atomoxetine—Chest pain—Methotrexate—ankylosing spondylitis	0.000566	0.00135	CcSEcCtD
Atomoxetine—Myalgia—Methotrexate—ankylosing spondylitis	0.000566	0.00135	CcSEcCtD
Atomoxetine—Decreased appetite—Prednisone—ankylosing spondylitis	0.000564	0.00135	CcSEcCtD
Atomoxetine—Rash—Prednisolone—ankylosing spondylitis	0.000563	0.00134	CcSEcCtD
Atomoxetine—Dermatitis—Prednisolone—ankylosing spondylitis	0.000563	0.00134	CcSEcCtD
Atomoxetine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—ankylosing spondylitis	0.000562	0.00134	CcSEcCtD
Atomoxetine—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.000561	0.00134	CcSEcCtD
Atomoxetine—Fatigue—Prednisone—ankylosing spondylitis	0.00056	0.00134	CcSEcCtD
Atomoxetine—Headache—Prednisolone—ankylosing spondylitis	0.00056	0.00134	CcSEcCtD
Atomoxetine—Constipation—Prednisone—ankylosing spondylitis	0.000555	0.00132	CcSEcCtD
Atomoxetine—Dizziness—Triamcinolone—ankylosing spondylitis	0.000543	0.0013	CcSEcCtD
Atomoxetine—Dizziness—Methylprednisolone—ankylosing spondylitis	0.000542	0.00129	CcSEcCtD
Atomoxetine—Infection—Methotrexate—ankylosing spondylitis	0.000539	0.00129	CcSEcCtD
Atomoxetine—Feeling abnormal—Prednisone—ankylosing spondylitis	0.000535	0.00128	CcSEcCtD
Atomoxetine—Asthenia—Dexamethasone—ankylosing spondylitis	0.000535	0.00128	CcSEcCtD
Atomoxetine—Asthenia—Betamethasone—ankylosing spondylitis	0.000535	0.00128	CcSEcCtD
Atomoxetine—Nervous system disorder—Methotrexate—ankylosing spondylitis	0.000532	0.00127	CcSEcCtD
Atomoxetine—Gastrointestinal pain—Prednisone—ankylosing spondylitis	0.000531	0.00127	CcSEcCtD
Atomoxetine—Nausea—Prednisolone—ankylosing spondylitis	0.000531	0.00127	CcSEcCtD
Atomoxetine—Pruritus—Dexamethasone—ankylosing spondylitis	0.000527	0.00126	CcSEcCtD
Atomoxetine—Pruritus—Betamethasone—ankylosing spondylitis	0.000527	0.00126	CcSEcCtD
Atomoxetine—Skin disorder—Methotrexate—ankylosing spondylitis	0.000527	0.00126	CcSEcCtD
Atomoxetine—Hyperhidrosis—Methotrexate—ankylosing spondylitis	0.000524	0.00125	CcSEcCtD
Atomoxetine—Vomiting—Triamcinolone—ankylosing spondylitis	0.000522	0.00125	CcSEcCtD
Atomoxetine—Vomiting—Methylprednisolone—ankylosing spondylitis	0.000521	0.00124	CcSEcCtD
Atomoxetine—Rash—Triamcinolone—ankylosing spondylitis	0.000518	0.00124	CcSEcCtD
Atomoxetine—Dermatitis—Triamcinolone—ankylosing spondylitis	0.000517	0.00123	CcSEcCtD
Atomoxetine—Anorexia—Methotrexate—ankylosing spondylitis	0.000517	0.00123	CcSEcCtD
Atomoxetine—Rash—Methylprednisolone—ankylosing spondylitis	0.000517	0.00123	CcSEcCtD
Atomoxetine—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.000516	0.00123	CcSEcCtD
Atomoxetine—Urticaria—Prednisone—ankylosing spondylitis	0.000516	0.00123	CcSEcCtD
Atomoxetine—Headache—Triamcinolone—ankylosing spondylitis	0.000515	0.00123	CcSEcCtD
Atomoxetine—Headache—Methylprednisolone—ankylosing spondylitis	0.000513	0.00123	CcSEcCtD
Atomoxetine—Abdominal pain—Prednisone—ankylosing spondylitis	0.000513	0.00122	CcSEcCtD
Atomoxetine—Body temperature increased—Prednisone—ankylosing spondylitis	0.000513	0.00122	CcSEcCtD
Atomoxetine—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.00051	0.00122	CcSEcCtD
Atomoxetine—Diarrhoea—Betamethasone—ankylosing spondylitis	0.00051	0.00122	CcSEcCtD
Atomoxetine—Musculoskeletal discomfort—Methotrexate—ankylosing spondylitis	0.000494	0.00118	CcSEcCtD
Atomoxetine—Dizziness—Dexamethasone—ankylosing spondylitis	0.000493	0.00118	CcSEcCtD
Atomoxetine—Dizziness—Betamethasone—ankylosing spondylitis	0.000493	0.00118	CcSEcCtD
Atomoxetine—Insomnia—Methotrexate—ankylosing spondylitis	0.000491	0.00117	CcSEcCtD
Atomoxetine—Nausea—Triamcinolone—ankylosing spondylitis	0.000488	0.00116	CcSEcCtD
Atomoxetine—Paraesthesia—Methotrexate—ankylosing spondylitis	0.000487	0.00116	CcSEcCtD
Atomoxetine—Nausea—Methylprednisolone—ankylosing spondylitis	0.000487	0.00116	CcSEcCtD
Atomoxetine—Somnolence—Methotrexate—ankylosing spondylitis	0.000482	0.00115	CcSEcCtD
Atomoxetine—Dyspepsia—Methotrexate—ankylosing spondylitis	0.000477	0.00114	CcSEcCtD
Atomoxetine—Vomiting—Dexamethasone—ankylosing spondylitis	0.000474	0.00113	CcSEcCtD
Atomoxetine—Vomiting—Betamethasone—ankylosing spondylitis	0.000474	0.00113	CcSEcCtD
Atomoxetine—Decreased appetite—Methotrexate—ankylosing spondylitis	0.000472	0.00113	CcSEcCtD
Atomoxetine—Rash—Betamethasone—ankylosing spondylitis	0.00047	0.00112	CcSEcCtD
Atomoxetine—Rash—Dexamethasone—ankylosing spondylitis	0.00047	0.00112	CcSEcCtD
Atomoxetine—Dermatitis—Dexamethasone—ankylosing spondylitis	0.000469	0.00112	CcSEcCtD
Atomoxetine—Dermatitis—Betamethasone—ankylosing spondylitis	0.000469	0.00112	CcSEcCtD
Atomoxetine—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	0.000468	0.00112	CcSEcCtD
Atomoxetine—Fatigue—Methotrexate—ankylosing spondylitis	0.000468	0.00112	CcSEcCtD
Atomoxetine—Headache—Dexamethasone—ankylosing spondylitis	0.000467	0.00111	CcSEcCtD
Atomoxetine—Headache—Betamethasone—ankylosing spondylitis	0.000467	0.00111	CcSEcCtD
Atomoxetine—Asthenia—Prednisone—ankylosing spondylitis	0.000466	0.00111	CcSEcCtD
Atomoxetine—Pain—Methotrexate—ankylosing spondylitis	0.000464	0.00111	CcSEcCtD
Atomoxetine—Pruritus—Prednisone—ankylosing spondylitis	0.000459	0.0011	CcSEcCtD
Atomoxetine—Feeling abnormal—Methotrexate—ankylosing spondylitis	0.000447	0.00107	CcSEcCtD
Atomoxetine—Diarrhoea—Prednisone—ankylosing spondylitis	0.000444	0.00106	CcSEcCtD
Atomoxetine—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	0.000444	0.00106	CcSEcCtD
Atomoxetine—Nausea—Betamethasone—ankylosing spondylitis	0.000443	0.00106	CcSEcCtD
Atomoxetine—Nausea—Dexamethasone—ankylosing spondylitis	0.000443	0.00106	CcSEcCtD
Atomoxetine—Urticaria—Methotrexate—ankylosing spondylitis	0.000431	0.00103	CcSEcCtD
Atomoxetine—Dizziness—Prednisone—ankylosing spondylitis	0.000429	0.00102	CcSEcCtD
Atomoxetine—Body temperature increased—Methotrexate—ankylosing spondylitis	0.000429	0.00102	CcSEcCtD
Atomoxetine—Abdominal pain—Methotrexate—ankylosing spondylitis	0.000429	0.00102	CcSEcCtD
Atomoxetine—Vomiting—Prednisone—ankylosing spondylitis	0.000413	0.000985	CcSEcCtD
Atomoxetine—Rash—Prednisone—ankylosing spondylitis	0.000409	0.000977	CcSEcCtD
Atomoxetine—Dermatitis—Prednisone—ankylosing spondylitis	0.000409	0.000976	CcSEcCtD
Atomoxetine—Headache—Prednisone—ankylosing spondylitis	0.000407	0.00097	CcSEcCtD
Atomoxetine—Asthenia—Methotrexate—ankylosing spondylitis	0.000389	0.000929	CcSEcCtD
Atomoxetine—Nausea—Prednisone—ankylosing spondylitis	0.000386	0.00092	CcSEcCtD
Atomoxetine—Pruritus—Methotrexate—ankylosing spondylitis	0.000384	0.000916	CcSEcCtD
Atomoxetine—Diarrhoea—Methotrexate—ankylosing spondylitis	0.000371	0.000886	CcSEcCtD
Atomoxetine—Dizziness—Methotrexate—ankylosing spondylitis	0.000359	0.000856	CcSEcCtD
Atomoxetine—Vomiting—Methotrexate—ankylosing spondylitis	0.000345	0.000823	CcSEcCtD
Atomoxetine—Rash—Methotrexate—ankylosing spondylitis	0.000342	0.000816	CcSEcCtD
Atomoxetine—Dermatitis—Methotrexate—ankylosing spondylitis	0.000342	0.000815	CcSEcCtD
Atomoxetine—Headache—Methotrexate—ankylosing spondylitis	0.00034	0.000811	CcSEcCtD
Atomoxetine—Nausea—Methotrexate—ankylosing spondylitis	0.000322	0.000769	CcSEcCtD
